CXCR4 involvement in neurodegenerative diseases
Luke W. Bonham,
Celeste M. Karch,
Chun C. Fan,
Chin Hong Tan,
Ethan G. Geier,
Iris J. Broce,
Matthew J. Barkovich,
John HardyInternational FTD-GWAS Consortium (IFGC)International Parkinson’s Disease Genetics Consortium (IPDGC)International Genomics of Alzheimer’s Project (IGAP),
Christopher P. Hess,
Leo P. Sugrue,
William P. Dillon,
Gerard D. Schellenberg,
Bruce L. Miller,
Ole A Andreassen,
Anders M Dale,
A. James Barkovich,
Jennifer S. Yokoyama,
Rahul S. Desikan
Posted 29 Aug 2017
bioRxiv DOI: 10.1101/181693 (published DOI: 10.1038/s41398-017-0049-7)
Posted 29 Aug 2017
Neurodegenerative diseases likely share common underlying pathobiology. Although prior work has identified susceptibility loci associated with various dementias, few, if any, studies have systematically evaluated shared genetic risk across several neurodegenerative diseases. Using genome-wide association data from large studies (total n = 82,337 cases and controls), we utilized a previously validated approach to identify genetic overlap and reveal common pathways between progressive supranuclear palsy (PSP), frontotemporal dementia (FTD), Parkinson's disease (PD) and Alzheimer's disease (AD). In addition to the MAPT H1 haplotype, we identified a variant near the chemokine receptor CXCR4 that was jointly associated with increased risk for PSP and PD. Using bioinformatics tools, we found strong physical interactions between CXCR4 and four microglia related genes, namely CXCL12, TLR2, RALB and CCR5. Evaluating gene expression from post-mortem brain tissue, we found that expression of CXCR4 and microglial genes functionally related to CXCR4 was dysregulated across a number of neurodegenerative diseases. Furthermore, in a mouse model of tauopathy, expression of CXCR4 and functionally associated genes was significantly altered in regions of the mouse brain that accumulate neurofibrillary tangles most robustly. Beyond MAPT, we show dysregulation of CXCR4 expression in PSP, PD, and FTD brains, and mouse models of tau pathology. Our multi-modal findings suggest that abnormal signaling across a network of microglial genes may contribute to neurodegeneration and may have potential implications for clinical trials targeting immune dysfunction in patients with neurodegenerative diseases.
- Downloaded 367 times
- Download rankings, all-time:
- Site-wide: 68,524
- In genetics: 3,197
- Year to date:
- Site-wide: 93,743
- Since beginning of last month:
- Site-wide: 82,468
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!